Apotex Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Apotex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013558
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Apotex Inc (Apotex) produces and markets a wide range of generic pharmaceuticals. It also undertakes the research, development, manufacture and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medical use. The company has research and development (R&D) facilities in Richmond Hill, Toronto, Etobicoke, Brantford, Windsor and Winnipeg. It has manufacturing and distribution facilities across the world and offers its products to patients, healthcare providers and payers, governments and other pharmaceutical manufacturers the world over. It operates through subsidiaries, joint ventures and licensing agreements in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Apotex is headquartered in Toronto, Ontario, Canada.

Apotex Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Apotex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Apotex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Apotex Inc, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Charterhouse Capital Partners Acquires Doc Generici For US$424 Million 10
Licensing Agreements 12
Panacea Biotec Expands Licensing Agreement with Apotex 12
Stada Arzneimittel Enters Into License Agreement With Apotex For Filgrastim 13
Cangene Enters Into Licensing Agreement With Apotex For Biotech Drugs 15
Acquisition 16
Apotex Acquires Aveva Drug Delivery Systems From Nitto Denko 16
Apotex Inc – Key Competitors 17
Apotex Inc – Key Employees 18
Apotex Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Legal and Regulatory 21
Oct 03, 2016: Apotex Files Lawsuit Seeking Compensation for “Improper” Government Actions 21
Other Significant Developments 22
Mar 08, 2017: Apotex Announces $184 Million Investment to Grow U.S. Manufacturing Presence; Expansion Plan Comprises Company’s Largest Investment in the United States 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Apotex Inc, Pharmaceuticals & Healthcare, Key Facts 2
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Apotex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Apotex Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Apotex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Charterhouse Capital Partners Acquires Doc Generici For US$424 Million 10
Panacea Biotec Expands Licensing Agreement with Apotex 12
Stada Arzneimittel Enters Into License Agreement With Apotex For Filgrastim 13
Cangene Enters Into Licensing Agreement With Apotex For Biotech Drugs 15
Apotex Acquires Aveva Drug Delivery Systems From Nitto Denko 16
Apotex Inc, Key Competitors 17
Apotex Inc, Key Employees 18
Apotex Inc, Subsidiaries 19

★海外企業調査レポート[Apotex Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Korea Gas Corp (036460):企業の財務・戦略的SWOT分析
    Korea Gas Corp (036460) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Interpace Diagnostics Group Inc (IDXG):医療機器:M&Aディール及び事業提携情報
    Summary Interpace Diagnostics Group Inc (Interpace Diagnostics), formerly PDI Inc is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathfinder platform. It …
  • BHP:企業の戦略・SWOT・財務情報
    BHP - Strategy, SWOT and Corporate Finance Report Summary BHP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing …
  • Aveng Ltd (AEG):企業の財務・戦略的SWOT分析
    Aveng Ltd (AEG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Dermira Inc (DERM):製薬・医療:M&Aディール及び事業提携情報
    Summary Dermira Inc (Dermira) is a biopharmaceutical company that identifies, develops and commercializes therapeutic solutions for the treatment of dermatologic diseases, such as hyperhidrosis, acne vulgaris and atopic dermatitis. The company’s product includes QBREXZA (glycopyrronium) cloth, an an …
  • Euler Hermes SA:戦略・SWOT・企業財務分析
    Euler Hermes SA - Strategy, SWOT and Corporate Finance Report Summary Euler Hermes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Straumann Holding AG (STMN):医療機器:M&Aディール及び事業提携情報
    Summary Straumann Holding AG (Straumann) is a provider of tooth replacement and orthodontic solutions. The company researches, develops, manufactures and markets dental implants, instruments, digital equipment, CADCAM prosthetics, dental biomaterials, software and clear aligners for application in t …
  • Quadra – Power Generation (TGKD):電力:M&Aディール及び事業提携情報
    Summary Quadra - Power Generation (Quadra) is an electric utility. It generates electricity and sells that on wholesale basis and in capacity market; and produces, transports, and sells thermal energy on retail market. The company has production facilities in Lipetsk, Voronezh, Tambov, Kursk, Belgor …
  • Kootenai Electric Cooperative Inc:企業の戦略的SWOT分析
    Kootenai Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • NextGen Healthcare Inc (NXGN):企業の財務・戦略的SWOT分析
    NextGen Healthcare Inc (NXGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Egyptian Resorts Co
    Egyptian Resorts Co - Strategy, SWOT and Corporate Finance Report Summary Egyptian Resorts Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PZ Cormay SA (CRM):医療機器:M&Aディール及び事業提携情報
    Summary PZ Cormay SA (Cormay) is a medical device company that produces and wholesale diagnostic reagents and laboratory equipment. The company provides products such as reagents, analyzers, coagulation, electrophoresis, urinalysis, rapid tests, assay sheets, and blood control instruments and equipm …
  • Argan Inc (AGX):企業の財務・戦略的SWOT分析
    Argan Inc (AGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • McKinsey & Company, Inc.:戦略・SWOT・企業財務分析
    McKinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary McKinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • MeiraGTx Holdings Plc (MGTX):製薬・医療:M&Aディール及び事業提携情報
    Summary MeiraGTx Holdings Plc (MeiraGTx) is an independent clinical-stage gene therapy company that focuses on the development of therapeutics for the treatment of eye, salivary gland and neurodegenerative diseases. The company’s pipeline of preclinical and research programs include AAV-CNGB3, for a …
  • The Walsh Group:企業の戦略的SWOT分析
    The Walsh Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • EpiVax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary EpiVax Inc (EpiVax) develops analytical capabilities in the field of computational immunology. Its product pipeline includes Tregitopes; deimmunization projects including deimmunized botox and deimmunized FVIII; and biodefense vaccines. Tregitopes are linear sequences of amino acids which ac …
  • Etex Group Sa:企業の戦略・SWOT・財務分析
    Etex Group Sa - Strategy, SWOT and Corporate Finance Report Summary Etex Group Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Dai Nippon Printing Co., Ltd.:企業の戦略・SWOT・財務情報
    Dai Nippon Printing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dai Nippon Printing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • PT Cikarang Listrindo (POWR):電力:M&Aディール及び事業提携情報
    Summary PT Cikarang Listrindo (Cikarang Listrindo) is a power company that generates and distributes electricity. The company offers services such as 24hours customer hotline, well trained security team, substation maintenance and calibration of kilo watt hour meters. It caters to automobile, electr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆